Table 1.
Patient characteristics.
| Arm | Laterality | STAGE | CHEMO | Concurrent | SITE | RT Fields | RT DOSE |
|---|---|---|---|---|---|---|---|
| P-RT | R | III | AC-T + P | P | CW + Sclav | 3 | 6000 |
| P-RT | L | III | AC-T + P | P | CW + Sclav | 3 | 6000 |
| P-RT | L | III | AC-T + P | P | CW + Sclav | 3 | 6000 |
| P-RT | R | III | AC-T + P | P | Intact | 2 | 6000 |
| P-RT | R | III | AC-T + P | P | Intact + Sclav | 3 | 6000 |
| P-RT | R | III | AC-T + P | P | CW + Sclav | 3 | 6000 |
| P-RT | L | III | AC-T + P + H | P + Herceptin | Intact + Sclav + IM | 3 | 6600 |
| P-RT | R | III | AC-T + P | P | Intact + Sclav | 3 | 6000 |
| P-RT | L | III | AC-T + P + H | P + Herceptin | CW + Sclav | 3 | 6000 |
| P-RT | L | III | AC-T + P | P | CW + Sclav | 3 | 6040 |
| P-RT | L | III | AC-T + P | P | CW + Sclav and axilla | 4 | 6000 |
| P-RT | L | III | AC-T + P | P | CW + Sclav | 3 | 6000 |
| RT | R | IV | AC-T | // | CW + Sclav | 3 | 6600 |
| RT | L | III | AC-T + H | Herceptin | CW + Sclav | 3 | 5800 |
| RT | L | III | AC-T + H | Herceptin | CW + Sclav | 3 | 6000 |
| RT | R | III | AC-T | // | Intact + Sclav, IM, PAB/AAB | 5 | 6000 |
| RT | R | III | AC-T | // | Intact + Sclav | 3 | 6000 |
| RT | L | III | TC, TAC | // | CW + Sclav | 3 | 6000 |
| RT | L | III | AC-T + H | Herceptin | CW + Sclav | 3 | 6000 |
| RT | L | III | TC + H | Herceptin | CW + Sclav | 3 | 6000 |
| RT | L | III | AC-T + H | Herceptin | CW + Sclav | 3 | 6000 |
| RT | L | III | // | // | CW | 2 | 6600 |
| RT | R | III | AC-T | // | Intact | 3 | 6000 |
| RT | L | III | TC + H | Herceptin | CW + Sclav | 3 | 6000 |
| RT | L | III | AC | // | CW + Sclav | 3 | 6000 |
| RT | L | III | AC-T | // | CW + Sclav | 3 | 6000 |
| RT | L | III | // | // | CW + Sclav | 3 | 6000 |
| RT | L | III | TC + H | Herceptin | CW + Sclav | 3 | 6000 |
| RT | R | III | // | // | Intact + Sclav | 3 | 6000 |
| RT | R | III | ECF | // | CW + Sclav | 3 | 6000 |
| RT | L | III | AC-T + H | Herceptin | CW + Sclav | 3 | 6000 |
| RT | R | III | AC-T | // | Intact + Sclav | 3 | 6000 |
| RT | R | III | AC-T | // | Intact + Sclav | 3 | 6000 |
| RT | R | III | TC, TAC | // | CW + Sclav | 3 | 6000 |
| RT | L | III | AC-T + H | Herceptin | CW + Sclav | 3 | 6000 |
| RT | L | III | TC + H | Herceptin | CW + Sclav | 3 | 6000 |
| RT | L | III | AC-T + H | Herceptin | CW + Sclav | 3 | 6000 |
Abbreviations: P: pazopanib; RT: radiotherapy; L: left; R: right; A: adriamycin; C: cytoxan; T: taxotere; H: herceptin; CW: chest wall; Sclav: supraclavicular; IM: internal mammary; PAB: posterior axillary boost; AAB: anterior axillary boost.